L-NAME in the cardiovascular system - nitric oxide synthase activator? - PubMed
Review
L-NAME in the cardiovascular system - nitric oxide synthase activator?
Jana Kopincová et al. Pharmacol Rep. 2012.
Free article
Abstract
L-arginine analogues are widely used inhibitors of nitric oxide synthase (NOS) activity both in vitro and in vivo, with N(ω)-nitro-L-arginine methyl ester (L-NAME) being at the head. On the one hand, acute and chronic L-NAME treatment leads to changes in blood pressure and vascular reactivity due to decreased nitric oxide (NO) bioavailability. However, lower doses of L-NAME may also activate NO production via feedback regulatory mechanisms if administered for longer time. Such L-NAME-induced activation has been observed in both NOS expression and activity and revealed considerable differences in regulatory mechanisms of NO production between particular tissues depending on the amount of L-NAME. Moreover, feedback activation of NO production by L-NAME seems to be regulated diversely under conditions of hypertension. This review summarizes the mechanisms of NOS regulation in order to better understand the apparent discrepancies found in the current literature.
Similar articles
-
Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.
Pechánová O, Dobesová Z, Cejka J, Kunes J, Zicha J. Pechánová O, et al. J Hypertens. 2004 Jan;22(1):167-73. doi: 10.1097/00004872-200401000-00026. J Hypertens. 2004. PMID: 15106808
-
Brinson KN, Elmarakby AA, Tipton AJ, Crislip GR, Yamamoto T, Baban B, Sullivan JC. Brinson KN, et al. Am J Physiol Regul Integr Comp Physiol. 2013 Oct 1;305(7):R701-10. doi: 10.1152/ajpregu.00226.2013. Epub 2013 Jul 24. Am J Physiol Regul Integr Comp Physiol. 2013. PMID: 23883679 Free PMC article.
-
Larson AA, Kovacs KJ, Cooper JC, Kitto KF. Larson AA, et al. Pain. 2000 May;86(1-2):103-11. doi: 10.1016/s0304-3959(00)00236-0. Pain. 2000. PMID: 10779667
-
Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B. Pfeiffer S, et al. Br J Pharmacol. 1996 Jul;118(6):1433-40. doi: 10.1111/j.1476-5381.1996.tb15557.x. Br J Pharmacol. 1996. PMID: 8832069 Free PMC article.
-
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity.
Maccallini C, Budriesi R, De Filippis B, Amoroso R. Maccallini C, et al. Int J Mol Sci. 2024 Aug 3;25(15):8486. doi: 10.3390/ijms25158486. Int J Mol Sci. 2024. PMID: 39126054 Free PMC article. Review.
Cited by
-
Arlt J, Vlaic S, Feuer R, Thomas M, Settmacher U, Dahmen U, Dirsch O. Arlt J, et al. BMC Med Genomics. 2022 Oct 7;15(1):211. doi: 10.1186/s12920-022-01364-z. BMC Med Genomics. 2022. PMID: 36207717 Free PMC article.
-
Tomasova L, Misak A, Kurakova L, Grman M, Ondrias K. Tomasova L, et al. Int J Mol Sci. 2020 Sep 12;21(18):6685. doi: 10.3390/ijms21186685. Int J Mol Sci. 2020. PMID: 32932738 Free PMC article.
-
Zeng S, Liu Z, Yin J, Li S, Jiang M, Yang H, Long Y. Zeng S, et al. Biomolecules. 2023 Dec 14;13(12):1792. doi: 10.3390/biom13121792. Biomolecules. 2023. PMID: 38136662 Free PMC article.
-
Berenyiova A, Dovinova I, Kvandova M, Kristek F, Jansen E, Majzunova M, Cacanyiova S. Berenyiova A, et al. Oxid Med Cell Longev. 2018 Jun 28;2018:2502843. doi: 10.1155/2018/2502843. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30050647 Free PMC article.
-
The effects of bacterial endotoxin LPS on synaptic transmission at the neuromuscular junction.
Cooper RL, McNabb M, Nadolski J. Cooper RL, et al. Heliyon. 2019 Mar 28;5(3):e01430. doi: 10.1016/j.heliyon.2019.e01430. eCollection 2019 Mar. Heliyon. 2019. PMID: 30976700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources